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Background: Practice guidelines recommend that patients with impaired ejection fraction (EF) after an acute myocardial infarction (AMI) be 
reassessed after 40 days to determine eligibility for a primary prevention implantable cardiac defibrillator (ICD). The degree to which this is adhered 
to in community practice is unknown.
Methods: We examined AMI patients in 24 hospitals participating in the TRIUMPH registry who had an EF<40% during the index AMI admission. We 
excluded patients with a prior ICD, or who declined ICD, died prior to discharge, or were discharged to hospice. We then identified characteristics of 
failing to receive EF reassessment by echocardiogram or stress imaging within 6 months of an AMI using chi-square and t-tests.
Results: Among 494 AMI patients with an initial EF<40% meriting consideration of ICD, only 101 (25.6%) had a reassessment of EF within 6 
months. This was not a consequence of early mortality (<2% at 1 year). Patients without interval EF reassessment had lower physical function and 
were more likely to have a prior CVA, yet no significant differences in sociodemographic or other clinical variables were observed (Table).
Conclusions: In community practice, 3 out of 4 AMI patients who are potential primary prevention ICD candidates failed to have guideline 
recommended follow-up EF evaluation. These results suggest an important gap in quality not driven by sociodemographic or clinical characteristics, 
and highlight the need for better AMI transition of care.
Interval EF Assessment(n=101) No EF Assessment (n=393) p
Age, median (IQR) 58.0 (50.0, 66.0) 58.0 (51.0, 66.0) 0.839
Female gender 27.7% 30.0% 0.651
White race 75.2% 69.0% 0.217
Has health Insurance 84.4% 76.1% 0.081
STEMI (vs. NSTEMI) 55.4% 50.6% 0.388
GRACE risk score, mean ± SD 102.2 ± 28.6 104.5 ± 28.8 0.489
Follow-up scheduled w/ Cardiologist 86.1% 82.2% 0.346
Prior stroke 1.0% 6.4% 0.031
SF-12 Physical Component Score, mean ± SD 42.1 ± 11.9 39.3 ± 12.8 0.050
